https://apnews.com/b5eff7d97025256b3ba759681131447f

NEW YORK (AP) — An expert panel backed a second COVID-19 vaccine option for kids ages 6 to 17 Thursday.

Advisers to the U.S. Centers for Disease Control and Prevention voted unanimously to recommend Moderna shots as an option for school-age kids and adolescents. This group has been able to get shots shots made by Pfizer since last year.